Silk Road Medical, Inc. SILK recently announced the launch of its Tapered ENROUTE Transcarotid Stent System in the United States, which is indicated for patients at high risk and standard risk for ...
SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has ...
HOLLYWOOD, FL—Carotid artery stenting (CAS) and endarterectomy (CEA) remain neck and neck in vying for prominence, but some experts say a minimally invasive surgical approach known as transcarotid ...
CHICAGO--(BUSINESS WIRE)--The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. There have now been more than 100,000 transcarotid ...
MIAMI, June 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today ...
SUNNYVALE, Calif., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that ROADSTER ...
(MENAFN- GlobeNewsWire - Nasdaq) Study represents a significant step forward in Company's mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solutions ...
Update on ICAD... Do We Still Stent and What is Standard Medical Therapy? Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results